A Single and Repeat Dose PK/PD Study to Characterise Biomarker Response in Healthy Subjects Treated With Azithromycin

NCT01416350 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Autoimmune Diseases

Interventions

DRUG: Azithromycin - 250 mg
DRUG: Azithromycin - 1000 mg
DRUG: Azithromycin - 250 mg every other day for 3 weeks

Sponsor

GlaxoSmithKline